Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Capricor Therapeutics, Inc. (CAPR) had Weighted-Average Shares Outstanding (Basic) of 46.48M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-30.17M |
|
-- |
|
-- |
|
$29.16M |
|
$-29.16M |
|
$-1.01M |
|
$-30.17M |
|
$-30.17M |
|
$-30.17M |
|
$-30.17M |
|
$-30.17M |
|
$-30.17M |
|
$-29.16M |
|
$-28.65M |
|
|
Weighted-Average Shares Outstanding (Basic) |
46.48M |
46.48M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$322.94M |
|
$18.31M |
|
$33.01M |
|
$355.95M |
|
$35.84M |
|
-- |
|
$14.32M |
|
$50.16M |
|
$305.79M |
|
$305.79M |
|
$305.79M |
|
64.95M |
|
| Cash Flow Statement Financials | |
$-69.81M |
|
$97.48M |
|
$248.89M |
|
$11.29M |
|
$287.85M |
|
$276.56M |
|
$16.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$179.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.87% |
|
-9.87% |
|
-8.48% |
|
-9.87% |
|
$4.71 |
|
$3.85 |
|
$-1.50 |
|